Long-term effectiveness and safety of biologic and small molecule drugs for moderate to severe atopic dermatitis: a systematic review

HIGHLIGHTS

• who: Angela Ayen-Rodríguez et al. from the Nursing Department, Faculty of Nursing, Physiotherapy and Podiatry, Sevilla University, Sevilla, Spain have published the research work: Long-Term Effectiveness and Safety of Biologic and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review, in the Journal: Life 2022, 1159 of 17/07/2022
• what: The risk of bias was analyzed with the Cochrane Risk of Bias Assessment (ROB-2) tool, focused on the primary objectives. This systematic review was carried out following the criteria included in the 2020 Preferred Reporting Items for . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.